title: Epidemiology of human parvovirus B19 in children with sickle cell disease.
abstract: Human parvovirus (HPV) B19 causes significant morbidity and mortality in children with sickle cell disease (SCD), but little data are published about the epidemiology of HPV B19 infection and its associated complications in this patient population. In this study, prevalence and incidence rates of HPV B19 were determined in 633 patients with SCD followed at The Children's Hospital of Philadelphia between November 1996 and December 2001. Thirty percent (30%) were HPV B19 immunoglobulin G (IgG) positive at first testing, and the 70% without evidence of past HPV B19 infection were tested annually. One hundred ten patients developed evidence of HPV B19 infection for an incidence rate of 11.3 per 100 patient years. Sixty-eight episodes of HPV B19-induced transient red cell aplasia occurred with the following clinical events: fever (89.7%), pain (61.8%), acute splenic sequestration (19.1%), and acute chest syndrome (11.8%). Pain, fever, and acute splenic sequestration were more frequent events with acute HPV B19 infections compared with acute events in uninfected patients. The results of this epidemiologic study, the largest and most comprehensive to date, justify the development of HPV B19 prevention strategies to diminish the frequent and often severe complications associated with HPV B19 infections in patients with SCD.
authors.affiliation: Division of Hematology, The Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, USA. whitleyk@email.chop.edu
authors.forename: Kim
authors.initials: K
authors.lastname: Smith-Whitley
authors.forename: Huaqing
authors.initials: H
authors.lastname: Zhao
authors.forename: Richard L
authors.initials: RL
authors.lastname: Hodinka
authors.forename: Janet
authors.initials: J
authors.lastname: Kwiatkowski
authors.forename: Renee
authors.initials: R
authors.lastname: Cecil
authors.forename: Tamara
authors.initials: T
authors.lastname: Cecil
authors.forename: Avital
authors.initials: A
authors.lastname: Cnaan
authors.forename: Kwaku
authors.initials: K
authors.lastname: Ohene-Frempong
mesh_terms: D000755:Anemia, Sickle Cell / Q000150:complications* / Q000276:immunology; D000914:Antibodies, Viral / Q000097:blood; D015331:Cohort Studies; D016731:Erythema Infectiosum / Q000453:epidemiology / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D010322:Parvoviridae Infections / Q000453:epidemiology* / Q000276:immunology; D016732:Parvovirus B19, Human / Q000276:immunology; D015143:Philadelphia / Q000453:epidemiology
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M